Search research articles
Contact Us
Filters
Showing results (111-120 of 180) with videos related to
Page
of 18
Sort By:
The Journal of Allergy and Clinical Immunology
|
April 27, 2017
The antimicrobial peptide human beta-defensin 2 promotes itch through Toll-like receptor 4 signaling in mice
Jing Feng, Jialie Luo, Madison R Mack, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 17, 2025
A multidisciplinary Delphi consensus on the modern definition of pruritus: Sensation and disease
Sonja Ständer, Martin Schmelz, Ethan Lerner, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
September 7, 2019
Association between fine mapping thymic stromal lymphopoietin and atopic dermatitis onset and persistence
Carolyn Lou, Nandita Mitra, Bradley Wubbenhorst, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
June 27, 2021
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies
Brian S Kim, Jonathan I Silverberg, Sonja Ständer, et al.
The Journal of Allergy and Clinical Immunology
|
February 25, 2014
Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis
Mario Noti, Brian S Kim, Mark C Siracusa, et al.
The Journal of Investigative Dermatology
|
February 1, 2020
PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes
Jiahui Zhao, Admire Munanairi, Xian-Yu Liu, et al.
Advances in Therapy
|
December 3, 2025
Efficacy of Lebrikizumab on Pruritus: A Narrative Review
Gil Yosipovitch, Brian S Kim, Sonja Ständer, et al.
Dermatology and Therapy
|
September 19, 2025
Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis
Sonja Ständer, Gil Yosipovitch, Brian S Kim, et al.
Science Translational Medicine
|
February 1, 2013
TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation
Brian S Kim, Mark C Siracusa, Steven A Saenz, et al.
Journal of the American Academy of Dermatology
|
September 16, 2022
Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies
Andrew Blauvelt, Jacek C Szepietowski, Kim Papp, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 180) with videos related to
Sort By:
Page
of 18
The Journal of Allergy and Clinical Immunology
|
April 27, 2017
The antimicrobial peptide human beta-defensin 2 promotes itch through Toll-like receptor 4 signaling in mice
Jing Feng, Jialie Luo, Madison R Mack, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 17, 2025
A multidisciplinary Delphi consensus on the modern definition of pruritus: Sensation and disease
Sonja Ständer, Martin Schmelz, Ethan Lerner, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
September 7, 2019
Association between fine mapping thymic stromal lymphopoietin and atopic dermatitis onset and persistence
Carolyn Lou, Nandita Mitra, Bradley Wubbenhorst, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
June 27, 2021
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies
Brian S Kim, Jonathan I Silverberg, Sonja Ständer, et al.
The Journal of Allergy and Clinical Immunology
|
February 25, 2014
Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis
Mario Noti, Brian S Kim, Mark C Siracusa, et al.
The Journal of Investigative Dermatology
|
February 1, 2020
PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes
Jiahui Zhao, Admire Munanairi, Xian-Yu Liu, et al.
Advances in Therapy
|
December 3, 2025
Efficacy of Lebrikizumab on Pruritus: A Narrative Review
Gil Yosipovitch, Brian S Kim, Sonja Ständer, et al.
Dermatology and Therapy
|
September 19, 2025
Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis
Sonja Ständer, Gil Yosipovitch, Brian S Kim, et al.
Science Translational Medicine
|
February 1, 2013
TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation
Brian S Kim, Mark C Siracusa, Steven A Saenz, et al.
Journal of the American Academy of Dermatology
|
September 16, 2022
Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies
Andrew Blauvelt, Jacek C Szepietowski, Kim Papp, et al.
Page
of 18